Afuco™ Anti-Human KLKB1 ADCC Therapeutic Antibody (DX-2930), ADCC Enhanced
Anti-KLKB1 ADCC Enhanced Antibody (DX-2930) is an ADCC enhanced antibody produced by our Afuco™ platform. DX-2930 is a fully human monoclonal antibody inhibitor of active plasma kallikrein. It is an investigational drug candidate in development for the prevention of hereditary angioedema (HAE) attacks.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-452CL |
| Pricing | Inquiry |
| Host | Human |
| Target | KLKB1 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Store it under sterile conditions at -20°C upon receiving. Recommend to pack the protein into smaller quantities for optimal storage. |